IIPLA News
Wednesday, May 13, 2026

UPM Expands Bio-Based Glycols Patent Portfolio with Acquisition of Avantium's Ray Technology® IP

The acquisition enhances UPM’s intellectual property rights in lignocellulosic biomass conversion, supporting its industrial-scale bio-based chemicals production in Europe.

IIPLA News Deskanonymous access0 articles left this week
UPM Expands Bio-Based Glycols Patent Portfolio with Acquisition of Avantium's Ray Technology® IP

UPM Kymmene Oyj announced on 13 May 2026 that it has entered into an agreement to acquire the intellectual property related to Avantium N.V.’s Ray Technology®. This technology encompasses a process for producing bio-based mono-ethylene glycol (MEG) and mono-propylene glycol (MPG) derived from plant-based sugars.

The transaction includes Avantium’s patent portfolio and invention disclosures associated with Ray Technology®. While the deal is not material in financial terms for UPM, its strategic importance lies in expanding UPM’s intellectual property position in the conversion of lignocellulosic biomass into bio-based glycols.

By acquiring this IP, UPM broadens the scope of its portfolio that safeguards biomass-to-glycols conversion pathways. This expansion adds flexibility for future process configurations as UPM continues to scale its bio-based chemicals business. Currently, UPM is commissioning its industrial-scale production at the Leuna biorefinery in Germany, which is the first of its kind to produce lignocellulosic biomass-based chemicals at scale.

UPM’s Chief Technology Officer and Executive Vice President of UPM Next Generation Renewables, Harald Dialer, emphasized the strategic value of the acquisition: "This acquisition is a focused step that strategically expands the scope of our IP portfolio in bio-based glycols and strengthens our freedom to operate as we scale the industrial production of renewable chemicals."

Dialer further noted that combining Avantium’s Ray Technology® patent estate with UPM’s existing platform broadens future process options and reinforces the premium market position UPM has established with its 100% UPM Bio PET™ product. He added, "This transaction confirms UPM's role as a frontrunner in building a competitive European industrial bioeconomy."

The acquisition aligns closely with Avantium, a recognized leader in renewable and circular polymer materials, supporting the rapid development of a strong industrial bioeconomy in Europe. The presence of multiple industrial options entering the market simultaneously is expected to accelerate scaling.

UPM Next Generation Renewables focuses on creating sustainable, wood-based alternatives to fossil raw materials. Its product range includes renewable glycols, lignin-based functional fillers, renewable diesel, and naphtha. With biorefineries in Lappeenranta, Finland, and Leuna, Germany, UPM scales high-quality, low-carbon solutions for textiles, packaging, plastics, transport fuels, and other applications.

The company aims to enable customers to reduce emissions, improve environmental performance, and accelerate the transition to a circular bioeconomy. UPM Next Generation Renewables supports brands, converters, and industries worldwide in achieving climate and sustainability targets confidently, envisioning a future where renewable materials and sustainable production become the norm.

UPM is a global material solutions company with a portfolio spanning renewable fibres, advanced materials, decarbonization solutions, and communication papers. The company employs approximately 15,100 people worldwide and reported annual sales of approximately €9.7 billion. UPM’s shares are listed on Nasdaq Helsinki Ltd.

Share This Article
Ready-to-post copy includes the article link.

UPM Expands Bio-Based Glycols Patent Portfolio with Acquisition of Avantium's Ray Technology® IP UPM has acquired the intellectual property rights to Avantium’s Ray Technology®, a process for producing bio-based mono-ethylene glycol (MEG) and mono-propylene glycol (MPG) from plant sugars. This strategic move broade... Read the full IIPLA article: https://iipla.org/news/upm-expands-bio-based-glycols-patent-portfolio-with-acquisition-of-avantium-s-ray-technology-ip

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

TJGC Group Limited Engages in Talks for Global AI and Robotics IP Licensing Agreement

TJGC Group Limited has announced ongoing negotiations for an intellectual property license agreement with a robotics technology provider. The proposed agreement would grant TJGC non-exclusive, global rights to commercialize certain artificial intelligence and robotics technologies within its intelligent automation pro…

Monday, August 10, 2026
PatentsGlobal

Hecht Partners Bolsters Patent Practice with Addition of Three Former KWM Attorneys

Hecht Partners has expanded its patent practice by recruiting three patent attorneys from King & Wood Mallesons (KWM). This move strengthens the firm’s expertise and capacity in patent prosecution and advisory services, positioning it for increased activity in intellectual property matters. The new team members bring…

Monday, August 10, 2026
PatentsGlobal

Temu Enhances Brand Protection with Advanced IP Enforcement and Seller Vetting

Temu has significantly expanded its intellectual property protection efforts, tripling the number of brands under proactive monitoring to over 15,000. Its 2026 Intellectual Property Protection Report details a multi-layered enforcement strategy combining seller vetting, proprietary screening technology, and direct rig…

Monday, August 10, 2026